Home > Insider Trading > Filing (0001140361-23-014284)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267602	Alimera Sciences Inc	ALIM	Pharmaceutical Preparations (2834)	200028718

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1306923	Palo Alto Investors Lp	470 University Avenue Palo Alto CA 94301		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-03-24	200,919	$1.56	0	No	4	S	Indirect	See note

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See note

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2023-03-24	600,000	$1.56	601,502	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-10-01		No	4	S	Indirect

Footnotes

Palo Alto Investors LP ("PAI") is the investment adviser to private funds, including Palo Alto Healthcare Master Fund, L.P. and Palo Alto Healthcare Master Fund II, L.P. (collectively, the "Funds"). Anthony Joonkyoo Yun, MD and Patrick Lee, MD are the managers and controlling owners of PAI. PAI may be deemed to indirectly beneficially own these securities as the investment adviser to the Funds. Dr. Yun and Dr. Lee may be deemed to indirectly beneficially own them as the control persons of PAI. No single Fund owns more than 10% of the outstanding shares of Common Stock. The reporting person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.
Each share of Series A Convertible Preferred Stock is convertible into shares of common stock at the rate equal to $40.00 divided by $39.90. The Series A Convertible Preferred Stock does not have an expiration date.